Avid Bioservices, Inc. financial data

Symbol
CDMO on Nasdaq
Industry
Pharmaceutical Preparations
Location
14191 Myford Road, Tustin, CA
State of incorporation
DE
Fiscal year end
April 30
Former names
PEREGRINE PHARMACEUTICALS INC (to 12/26/2017), TECHNICLONE CORP/DE/ (to 7/31/2000), TECHNICLONE INTERNATIONAL CORP (to 2/11/1997)
Latest financial report
10-Q - Q3 2024 - Dec 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 92.9 % +80.5%
Quick Ratio 27.9 % +43.7%
Debt-to-equity 321 % +128%
Return On Equity -177 % -2600%
Return On Assets -42 % -1445%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64M shares +1.15%
Common Stock, Shares, Outstanding 64M shares +1.14%
Entity Public Float 386M USD -56.5%
Common Stock, Value, Issued 64K USD +1.59%
Weighted Average Number of Shares Outstanding, Basic 63.8M shares +1.09%
Weighted Average Number of Shares Outstanding, Diluted 63.8M shares +1.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33.5M USD +31.8%
Revenue from Contract with Customer, Excluding Assessed Tax 150M USD +6.75%
Costs and Expenses 27.5M USD -4.01%
Operating Income (Loss) -20.4M USD -107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -35.2M USD -204%
Income Tax Expense (Benefit) 117M USD +17928%
Net Income (Loss) Attributable to Parent -152M USD -1144%
Earnings Per Share, Basic -2.41 USD/shares -1168%
Earnings Per Share, Diluted -2.41 USD/shares -1168%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.4M USD +6.34%
Marketable Securities, Current 1.7M USD -77.3%
Accounts Receivable, after Allowance for Credit Loss, Current 18.4M USD +37.6%
Inventory, Net 28.1M USD -27.2%
Assets, Current 96.5M USD -7.39%
Deferred Income Tax Assets, Net 118M USD +2.64%
Property, Plant and Equipment, Net 182M USD -3%
Operating Lease, Right-of-Use Asset 40.3M USD -3.94%
Other Assets, Noncurrent 4.41M USD -5.59%
Assets 323M USD -29%
Accounts Payable, Current 9.25M USD -59.4%
Employee-related Liabilities, Current 8.22M USD +93.7%
Contract with Customer, Liability, Current 51.7M USD +11.3%
Liabilities, Current 74.2M USD -66.2%
Operating Lease, Liability, Noncurrent 43.6M USD -3.21%
Liabilities 279M USD +2.4%
Retained Earnings (Accumulated Deficit) -595M USD -34.3%
Stockholders' Equity Attributable to Parent 44.8M USD -75.6%
Liabilities and Equity 323M USD -29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.68M USD -1459%
Net Cash Provided by (Used in) Financing Activities 266K USD -64.4%
Net Cash Provided by (Used in) Investing Activities -1.31M USD +90.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 64M shares +1.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33.4M USD +6.34%
Interest Paid, Excluding Capitalized Interest, Operating Activities 27K USD +17.4%
Deferred Tax Assets, Valuation Allowance 118M USD
Deferred Tax Assets, Gross 145M USD +3.93%
Payments to Acquire Property, Plant, and Equipment 1.31M USD -90.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -152M USD -1144%
Property, Plant and Equipment, Gross 226M USD +1.46%
Operating Lease, Liability, Current 1.45M USD +14.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 115M USD +2.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 973K USD -13%
Additional Paid in Capital 640M USD +2.16%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.82M USD +6.61%
Deferred Tax Assets, Net of Valuation Allowance 26.7M USD -80.9%
Interest Expense 8.42M USD +186%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%